BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 21221826)

  • 1. Angiogenesis and invasion in glioma.
    Onishi M; Ichikawa T; Kurozumi K; Date I
    Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion molecules and the extracellular matrix as drug targets for glioma.
    Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
    Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.
    Onishi M; Kurozumi K; Ichikawa T; Date I
    Neurol Med Chir (Tokyo); 2013; 53(11):755-63. PubMed ID: 24162241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
    Grobben B; De Deyn PP; Slegers H
    Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma.
    Onishi M; Ichikawa T; Kurozumi K; Inoue S; Maruo T; Otani Y; Fujii K; Ishida J; Shimazu Y; Yoshida K; Michiue H; Antonio Chiocca E; Date I
    Brain Tumor Pathol; 2015 Jul; 32(3):184-94. PubMed ID: 25697644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
    Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S
    Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in malignant gliomas.
    Plate KH; Risau W
    Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of angiogenesis and invasion in glioma.
    Tate MC; Aghi MK
    Neurotherapeutics; 2009 Jul; 6(3):447-57. PubMed ID: 19560735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasion as limitation to anti-angiogenic glioma therapy.
    Lamszus K; Kunkel P; Westphal M
    Acta Neurochir Suppl; 2003; 88():169-77. PubMed ID: 14531575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging and response criteria in gliomas.
    Gerstner ER; Batchelor TT
    Curr Opin Oncol; 2010 Nov; 22(6):598-603. PubMed ID: 20689430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the tumor vasculature to improve the efficacy of oncolytic virus therapy.
    Rhim JH; Tosato G
    J Natl Cancer Inst; 2007 Dec; 99(23):1739-41. PubMed ID: 18042930
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-angiogenesis treatment for brain tumors--present and future].
    Takano S
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():534-9. PubMed ID: 16201577
    [No Abstract]   [Full Text] [Related]  

  • 20. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA.
    Lin CY; Siow TY; Lin MH; Hsu YH; Tung YY; Jang T; Recht L; Chang C
    Angiogenesis; 2013 Oct; 16(4):785-93. PubMed ID: 23736837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.